Chinese General Practice ›› 2025, Vol. 28 ›› Issue (18): 2294-2300.DOI: 10.12114/j.issn.1007-9572.2024.0261
Special Issue: 心肌梗死最新文章合辑
• Frontiers of Medicine • Previous Articles Next Articles
Received:
2024-05-20
Revised:
2024-09-27
Published:
2025-06-20
Online:
2025-04-25
Contact:
HE Guixin
通讯作者:
何贵新
作者简介:
作者贡献:
朱子一负责文章的构思与设计、论文撰写;何贵新、秦伟彬负责论文修订、文章的质量控制及审校、对文章整体负责,监督管理;朱子一、宋惠、张利文、唐伟智、杨斐斐、刘凌云、欧阳彬负责研究资料的收集与整理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0261
[1] |
马丽媛,王增武,樊静,等. 《中国心血管健康与疾病报告2022》要点解读[J]. 中国全科医学,2023,26(32):3975-3994. DOI:10.12114/j.issn.1007-9572.2023.0408.
|
[2] |
|
[3] |
|
[4] |
|
[5] |
袁文慧,刘剑芳,王梦龙,等. 心血管疾病中心肌纤维化与自噬的相关性研究进展[J]. 中国心血管病研究,2017,15(3):197-200. DOI:10.3969/j.issn.1672-5301.2017.03.002.
|
[6] |
|
[7] |
|
[8] |
|
[9] |
冯雨菲,何贵新,胡梦弦,等. 从线粒体功能障碍探讨心血管疾病作用机制及中药复方干预治疗研究进展[J]. 辽宁中医药大学学报,2022,24(4):97-102. DOI:10.13194/j.issn.1673-842x.2022.04.021.
|
[10] |
|
[11] |
|
[12] |
殷玉,许志亮,刘刚. 线粒体自噬在纤维化疾病中作用的研究进展[J]. 中华实用诊断与治疗杂志,2022,36(1):102-105. DOI:10.13507/j.issn.1674-3474.2022.01.025.
|
[13] |
|
[14] |
李开,饶莉. 线粒体自噬的分子生物学过程及其在心脏疾病中的作用[J]. 心血管病学进展,2022,43(3):222-224,228. DOI:10.16806/j.cnki.issn.1004-3934.2022.03.008.
|
[15] |
|
[16] |
|
[17] |
|
[18] |
刘亦伟,周静,高峰. 心肌梗死后心肌纤维化的发生机制、诊断及治疗的相关研究进展[J]. 智慧健康,2022,8(5):21-25. DOI:10.19335/j.cnki.2096-1219.2022.05.007.
|
[19] |
|
[20] |
李金城,杨杰,黄周,等. PINK1/Parkin通路调控线粒体自噬对大鼠急性心肌梗死细胞的影响研究[J]. 蛇志,2023,35(1):23-25,52. DOI:10.3969/j.issn.1001-5639.2023.01.006.
|
[21] |
李伟,赵卓,赵添,等. 细胞自噬与心室重构的相关研究进展[J]. 心肺血管病杂志,2022,41(4):436-439. DOI:10.3969/j.issn.1007-5062.2022.04.021.
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] | |
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
王永正,苏先华,林金. 白藜芦醇通过抑制SIRT3/β-catenin/PPARγ信号通路对急性心肌梗死大鼠心肌细胞凋亡的影响[J]. 四川中医,2021,39(8):39-42.
|
[32] |
李想. 栝楼薤白半夏汤对心肌缺血再灌注损伤大鼠线粒体自噬及PINK1/Parkin通路作用机制研究[D]. 昆明:云南中医药大学,2020. DOI:10.27460/d.cnki.gyzyc.2020.000296.
|
[33] |
|
[34] |
|
[35] |
张文静,李晓峰,孙明明,等. 线粒体自噬在心肌梗死中的作用及研究进展[J]. 中华全科医学,2022,20(7):1194-1198. DOI:10.16766/j.cnki.issn.1674-4152.002556.
|
[36] |
|
[37] |
|
[38] |
郑霞. 线粒体靶向性H2S供体AP39通过抑制过度线粒体自噬改善心肌梗死大鼠心肌纤维化[D]. 衡阳:南华大学,2021.
|
[39] |
|
[40] |
王春淼. 参莲提取物通过调控线粒体自噬干预炎症小体活化抗大鼠心肌梗死的研究[D]. 北京:中国中医科学院,2021. DOI:10.27658/d.cnki.gzzyy.2021.000098.
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
辛高杰. 双参宁心胶囊调控FUNDC1介导的线粒体自噬保护心肌缺血再灌注损伤机制研究[D]. 北京:中国中医科学院,2020. DOI:10.27658/d.cnki.gzzyy.2020.000191.
|
[48] |
|
[49] |
|
[50] |
吴云娇,黄锋,卢创宏,等. HMGB1介导线粒体自噬参与糖尿病小鼠心肌缺血/再灌注损伤[J]. 广西医科大学学报,2021,38(4):655-661. DOI:10.16190/j.cnki.45-1211/r.2021.04.005.
|
[51] |
|
[52] | |
[53] |
吴瑛滢,陈竞纬. 自噬在心血管疾病中的影响及中药的干预作用[J]. 实用中西医结合临床,2017,17(7):160-162. DOI:10.13638/j.issn.1671-4040.2017.07.104.
|
[54] |
黄淑敏,李书楠,钟森杰,等. 基于"正邪理论"探讨自噬在慢性心力衰竭发展中的作用[J]. 中国实验方剂学杂志,2022,28(12):233-239. DOI:10.13422/j.cnki.syfjx.20221296.
|
[55] |
周家谭,卢健棋,罗文宽,等. 中医药调控线粒体自噬相关信号通路防治心力衰竭的研究进展[J]. 广西中医药大学学报,2023,26(4):66-70. DOI:10.3969/j.issn.2095-4441.2023.04.018.
|
[56] |
王新宇. 线粒体自噬-NLRP3炎症小体轴介导丹酚酸B对心肌缺血损伤的保护作用[D]. 南京:南京中医药大学,2017.
|
[57] |
齐苗苗. 黄芪甲苷通过PINK1/Parkin介导线粒体自噬改善心肌细胞氧化应激损伤的研究[D]. 兰州:兰州大学,2021. DOI:10.27204/d.cnki.glzhu.2021.002986.
|
[58] |
|
[59] |
|
[60] |
|
[61] |
魏东明,徐臣年,刘洋,等. 积雪草苷通过Notch1/Hes1信号上调自噬减轻糖尿病心肌病心肌损伤的作用及机制[J]. 山西医科大学学报,2022,53(3):305-311. DOI:10.13753/j.issn.1007-6611.2022.03.008.
|
[62] |
程相阁,刘万周,王东伟. 淫羊藿苷对心力衰竭大鼠线粒体自噬及能量代谢的影响[J]. 西北药学杂志,2022,37(4):51-57. DOI:10.3969/j.issn.1004-2407.2022.04.009.
|
[63] |
|
[64] |
汪刘洋. 芪参益气滴丸通过内源性H2S调控PINK1/Parkin介导的线粒体自噬抑制铁死亡改善心肌梗死后心肌纤维化[D]. 衡阳:南华大学,2023.
|
[65] |
赵新军,黎燚华,康亮,等. 金欣康颗粒提高线粒体自噬蛋白LC3/Beclin1表达改善心力衰竭大鼠心肌纤维化的研究[J]. 中药新药与临床药理,2023,34(6):713-721. DOI:10.19378/j.issn.1003-9783.2023.06.001.
|
[66] |
|
[67] |
|
[68] |
|
[69] |
|
[70] |
李亭亭,陈捷,吉恩生,等. 当归补血汤含药血清对间歇性低氧暴露H9c2心肌细胞损伤的作用及机制[J]. 中国中药杂志,2023,48(21):5881-5887. DOI:10.19540/j.cnki.cjcmm.20230614.703.
|
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | JIA Gaopeng, CHEN Qiuyu. Construction and Validation of a Risk Prediction Model for Recurrent Angina after Percutaneous Coronary Intervention in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction: Based on CYP2C19-related Genetic Testing [J]. Chinese General Practice, 2025, 28(30): 3779-3786. |
[4] | LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740. |
[5] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[6] | CUI Yiyuan, YAN Yijing, WANG Ying, MENG Xiangju, ZHANG Qinglin, LIU Lixing, LI Sicong, FENG Li, The Working Group for the Clinical Practice Guideline for the Cancer-related Fatigue with Integrated Traditional Chinese and Western Medicine. Clinical Practice Guideline for the Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Cancer-related Fatigue [J]. Chinese General Practice, 2025, 28(27): 3345-3358. |
[7] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[8] | ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei. Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy [J]. Chinese General Practice, 2025, 28(26): 3307-3313. |
[9] | HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling. Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction [J]. Chinese General Practice, 2025, 28(24): 2979-2984. |
[10] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[11] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[12] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[13] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[14] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[15] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||